SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 130 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $109,000 | +9.0% | 14,630 | -4.5% | 0.00% | 0.0% |
Q1 2017 | $100,000 | +29.9% | 15,320 | -11.3% | 0.00% | +50.0% |
Q4 2016 | $77,000 | -3.8% | 17,280 | +0.6% | 0.00% | 0.0% |
Q3 2016 | $80,000 | -29.8% | 17,170 | -1.1% | 0.00% | -33.3% |
Q2 2016 | $114,000 | +3.6% | 17,360 | +0.1% | 0.00% | 0.0% |
Q1 2016 | $110,000 | -2.7% | 17,350 | -7.7% | 0.00% | 0.0% |
Q4 2015 | $113,000 | +0.9% | 18,790 | +0.4% | 0.00% | 0.0% |
Q3 2015 | $112,000 | -5.1% | 18,710 | +8.2% | 0.00% | 0.0% |
Q2 2015 | $118,000 | -22.9% | 17,300 | -31.3% | 0.00% | -25.0% |
Q1 2015 | $153,000 | -11.0% | 25,180 | +1.2% | 0.00% | -20.0% |
Q4 2014 | $172,000 | -27.1% | 24,890 | -14.2% | 0.01% | -37.5% |
Q3 2014 | $236,000 | -1.7% | 29,020 | -1.5% | 0.01% | 0.0% |
Q2 2014 | $240,000 | +9.6% | 29,470 | +5.3% | 0.01% | +14.3% |
Q1 2014 | $219,000 | -13.1% | 27,983 | -1.7% | 0.01% | 0.0% |
Q4 2013 | $252,000 | -19.0% | 28,453 | -23.3% | 0.01% | -12.5% |
Q3 2013 | $311,000 | +14.8% | 37,083 | +2.2% | 0.01% | +14.3% |
Q2 2013 | $271,000 | – | 36,273 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
CM Management, LLC | 600,000 | $468,000 | 0.50% |
ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
Ergoteles LLC | 744,275 | $581,000 | 0.02% |
Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |